The Centers for Disease Control and Prevention has recommended the first RSV vaccine for pregnant people to protect their newborns from severe RSV illness. According to a press release, “This new vaccine, Pfizer’s bivalent RSVpreF vaccine (trade name Abrysvo TM), has been shown to reduce the risk of RSV hospitalization for babies by 57 percent in the first six months after birth. To maximize protection for babies after birth, CDC recommends seasonal administration of one dose of RSV vaccine for pregnant people during weeks 32 through 36 of pregnancy.” ■ cdc.gov